BENITIONSClinical Trial Intelligence

Tracking Post-stroke Walking Improvements From the Clinic Into the Home

該当なし 完了 NCT05454007

対象疾患Stroke, Healthy Adult
該当なし
スポンサーWestern University of Health Sciences
ステータス完了
参加者数53 名
介入(薬剤)Step length asymmetry training
開始日2022年8月25日
完了日2025年3月9日
結果公開日2026年7月24日

概要

The purpose of this proposal is to use novel video-based movement tracking technology to measure gait quality after stroke - in the home. Current rehabilitation practice assesses walking in the highly controlled 'ideal' clinical environment. The implicit assumption by clinicians and researchers is that the way people walk in the clinic (their best capacity) reflects the way they walk in the real-world (true performance). With advances in computer vision and development of pose estimation algorithms, it is now possible to directly measure how people are walking in their homes. It is critical that researchers apply this technology to examine the basic assumptions that underlie current rehabilitation practice. Here, a video-based pose estimation workflow will be used to 1) contrast the gait patterns of persons post-stroke as observed in-clinical vs. in-home settings, and 2) map the rate of deterioration of clinically-derived walking improvements, in the home. This methodology has been used to accurately measure gait kinematics in people with stroke as they walk in laboratory, however this study now seeks to use these methods to record people with stroke as they walk in their natural h

Step Length Asymmetry

In-clinic baseline (day 1), in-home baseline (day 1) · unitless

Individuals With Stroke0.12 ± 0.11 unitless
Neurologically Intact Adults0.07 ± 0.07 unitless
Individuals With Stroke0.15 ± 0.11 unitless
Neurologically Intact Adults0.07 ± 0.04 unitless

Step Time Symmetry

In-clinic baseline (day 1), in-home baseline (day 1) · unitless

Individuals With Stroke0.10 ± 0.14 unitless
Neurologically Intact Adults0.05 ± 0.07 unitless
Individuals With Stroke0.11 ± 0.15 unitless
Neurologically Intact Adults0.04 ± 0.02 unitless

Self Selected Gait Speed

In-clinic baseline (day 1), in-home baseline (day 1) · m/s

Individuals With Stroke0.70 ± 0.38 m/s
Neurologically Intact Adults1.01 ± 0.28 m/s
Individuals With Stroke0.73 ± 0.47 m/s
Neurologically Intact Adults1.07 ± 0.64 m/s

BENITIONS で見る ClinicalTrials.gov の原文を見る

同じ疾患の他の治験

すべての治験

このページは ClinicalTrials.gov の公開データをまとめたものです。医学的助言ではなく、投資助言でもありません。必ず専門医にご相談ください。